{"gene":"DCP2","run_date":"2026-06-09T23:54:41","timeline":{"discoveries":[{"year":1999,"finding":"Yeast Dcp2 is required for mRNA decapping of both normal mRNAs and NMD substrates; its MutT/Nudix motif is necessary and sufficient for decapping function; Dcp2 co-immunoprecipitates with Dcp1 and is required for production of enzymatically active decapping enzyme, indicating direct or indirect Dcp1-Dcp2 interaction is needed for activity.","method":"Genetic suppressor screen, co-immunoprecipitation, mutational analysis, in vivo mRNA decay assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (genetics, Co-IP, mutagenesis, in vivo decay), foundational paper replicated across many subsequent studies","pmids":["10508173"],"is_preprint":false},{"year":2002,"finding":"Human Dcp2 (hDcp2) is the catalytically active decapping enzyme; its MutT/Nudix domain mediates activity; it generates m7GDP and 5'-phosphorylated mRNA products; hDcp1 and hDcp2 co-localize in specific cytoplasmic foci (P-bodies); Dcp2 activity is evolutionarily conserved.","method":"Recombinant protein expression, in vitro decapping assay, mutational analysis, immunofluorescence co-localization","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro biochemical reconstitution with mutagenesis, direct localization experiments, replicated across species","pmids":["12486012"],"is_preprint":false},{"year":2005,"finding":"The DCP1:DCP2 decapping complex is required for miRNA-mediated gene silencing in Drosophila cells; depletion of DCP1 or DCP2 inhibits miRNA-mediated decay of reporter mRNAs.","method":"RNAi depletion in Drosophila S2 cells, reporter assays","journal":"RNA (New York, N.Y.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean loss-of-function with defined pathway phenotype, single lab","pmids":["16177138"],"is_preprint":false},{"year":2005,"finding":"Nematode Dcp2 decaps both m7GpppG- and m2,2,7GpppG (trimethylguanosine)-capped RNAs; Dcp2 activity is influenced by the sequence and structural context of the 5' end of the mRNA substrate; budding yeast and human Dcp2 are also active on trimethylguanosine-capped substrates; Dcp1 does not significantly enhance Dcp2 activity in nematodes.","method":"In vitro decapping assays with cap analogs, competing RNA, recombinant proteins","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro biochemical reconstitution across three species with substrate competition assays","pmids":["16199859"],"is_preprint":false},{"year":2006,"finding":"mRNA degradation by miRNAs and GW182 in Drosophila requires both the CCR4:NOT deadenylase complex and the DCP1:DCP2 decapping complex; depletion of DCP1 or DCP2 inhibits mRNA decay but not translational repression by miRNAs.","method":"RNAi depletion, reporter mRNA stability assays, polysome analysis in Drosophila S2 cells","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods, replicated across multiple pathway components, well-cited","pmids":["16815998"],"is_preprint":false},{"year":2007,"finding":"Human Dcp2 preferentially binds and decaps a subset of mRNAs; a 60-nucleotide element at the 5' terminus of Rrp41 mRNA serves as a specific Dcp2 substrate; reduction of hDcp2 levels selectively stabilizes Rrp41 mRNA in cells, demonstrating transcript-specific regulation.","method":"RNA immunoprecipitation, in vitro decapping assays, RNAi knockdown with mRNA stability measurement","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (biochemistry + cell-based), single lab","pmids":["18039849"],"is_preprint":false},{"year":2008,"finding":"Yeast Dcp2 uses a bipartite RNA-binding surface forming a channel that intersects the catalytic and Dcp1-binding regulatory domains; cap binding is weak but specific and requires RNA body contact; Dcp1 stimulates the catalytic step of decapping through a substrate-induced conformational change.","method":"NMR spectroscopy, enzyme kinetics","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — NMR structural analysis combined with kinetic dissection, multiple orthogonal methods","pmids":["18280238"],"is_preprint":false},{"year":2008,"finding":"Crystal structure of S. pombe Dcp1-Dcp2 complex combined with SAXS reveals Dcp2 adopts open and closed conformations; the closed conformation is catalytically more active; a bipartite RNA-binding channel containing the active site is identified; Dcp1 stimulates Dcp2 activity by promoting/stabilizing the closed conformation.","method":"X-ray crystallography, SAXS, enzyme activity assays, mutagenesis","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with SAXS and mutagenesis, multiple orthogonal methods in one study","pmids":["18280239"],"is_preprint":false},{"year":2009,"finding":"Enhanced decapping by Dcp2 depends on a stem-loop structure within the first 33 nucleotides of target mRNAs, not primary sequence; 5'-proximal stem-loops generally enhance Dcp2-mediated decapping; Dcp2 alone can preferentially associate with and decap stem-loop-containing substrates without additional proteins.","method":"In vitro decapping assays, mutational analysis of RNA secondary structure, transfection assays","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with structured substrate analysis, single lab","pmids":["19233875"],"is_preprint":false},{"year":2010,"finding":"Yeast Dcp2 is phosphorylated on serine 137 by the Ste20 kinase during stress; this phosphorylation affects decay of specific mRNAs, is required for Dcp2 accumulation in P-bodies, modulates specific protein interactions of Dcp2, and is required for efficient stress granule formation.","method":"In vivo phosphorylation mapping, kinase assays with Ste20, P-body fluorescence microscopy, mRNA decay assays in yeast mutants","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — identified kinase writer, mapped phosphorylation site, multiple functional readouts, direct localization experiments","pmids":["20513766"],"is_preprint":false},{"year":2010,"finding":"Edc3 binding to yeast Dcp2 is mediated by a short peptide sequence C-terminal to the catalytic domain of Dcp2; this interaction is required for Edc3 to stimulate Dcp2 decapping activity in vitro, for Dcp2 accumulation in P-bodies, and for efficient degradation of RPS28B mRNA.","method":"Mutational analysis, in vitro decapping assays, P-body fluorescence microscopy, mRNA decay assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (biochemistry, cell biology, genetics) defining a specific interaction domain","pmids":["20086104"],"is_preprint":false},{"year":2010,"finding":"Dcp1 couples coactivator binding to Dcp2 activation; Edc1 and Edc2 bind Dcp1 via its EVH1 proline recognition site and stimulate decapping 1000-fold, affecting both substrate KM and catalytic rate; the Dcp1 EVH1 domain or Edc1 proline-rich sequence mutations block stimulation.","method":"Enzyme kinetics, mutagenesis, binding assays","journal":"RNA (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 / Strong — quantitative kinetic analysis with mutagenesis defining mechanism","pmids":["21148770"],"is_preprint":false},{"year":2011,"finding":"Crystal structure of yeast Edc3 LSm domain bound to a helical leucine-rich motif (HLM) from Dcp2 reveals the structural basis of interaction; multiple HLMs in the Dcp2 C-terminal extension bind Edc3; Edc3 and related Scd6 compete for the same HLMs on Dcp2; Edc3 and Scd6 stimulate decapping in vitro; C-terminal HLMs are necessary for Dcp1:Dcp2 localization to P-bodies in vivo.","method":"X-ray crystallography, in vitro decapping assays, P-body fluorescence microscopy, mutagenesis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with functional validation by in vitro assays and cell biology","pmids":["22085934"],"is_preprint":false},{"year":2012,"finding":"Tryptophan 43 of S. pombe Dcp2 is a conserved gatekeeper of the open-to-closed conformational transition; Dcp2 samples multiple conformations on millisecond-microsecond timescales; mutation of this tryptophan abolishes dynamic behavior and attenuates coactivation by Edc1.","method":"NMR spectroscopy, enzyme kinetics, mutagenesis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — NMR dynamics combined with mutagenesis and kinetics, multiple orthogonal methods","pmids":["22323607"],"is_preprint":false},{"year":2012,"finding":"Mouse Dcp2 modulates IRF-7 mRNA stability; cells with reduced Dcp2 (Dcp2β/β) show increased IRF-7 mRNA and protein due to IRF-7 mRNA stabilization; Dcp2 expression is induced upon viral infection, suggesting a negative feedback role in the innate immune response.","method":"Dcp2 hypomorphic mouse cells, mRNA stability assays, quantitative RT-PCR, immunoblot","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined cellular phenotype with mRNA stability measurement, single lab","pmids":["22252322"],"is_preprint":false},{"year":2013,"finding":"Crystal structures of the Dcp2 catalytic Nudix domain reveal binding of a catalytically essential metal ion; active site residues involved in acid/base chemistry of decapping are identified by kinetic analysis; a conserved metal-binding loop undergoes conformational changes during the catalytic cycle as shown by NMR and molecular dynamics.","method":"X-ray crystallography, enzyme kinetics (mutagenesis), NMR, molecular dynamics simulations","journal":"Structure (London, England : 1993)","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus NMR plus kinetics and mutagenesis, multiple orthogonal methods","pmids":["23911090"],"is_preprint":false},{"year":2013,"finding":"Dcp2, the catalytic decapping component, and decapping activators DDX6 and LSM7 are antiviral against bunyaviruses in Drosophila; RVFV cap-snatches from Dcp2-targeted mRNAs; loss of Dcp2 increases viral transcription without affecting viral mRNA stability, while Dcp2 overexpression impedes viral transcription.","method":"Genome-wide RNAi screen, gain/loss-of-function in cells and flies, RNA-seq, cap-snatching analysis","journal":"Genes & development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined functional role in viral restriction with mechanistic underpinning, multiple readouts, single lab","pmids":["23824541"],"is_preprint":false},{"year":2013,"finding":"Maternally recruited DCP1A and DCP2 are translated during mouse oocyte maturation via cytoplasmic polyadenylation; both proteins are phosphorylated during maturation with CDC2A as the likely kinase; inhibition of DCP1A and DCP2 decreases maternal mRNA degradation during meiotic maturation and impairs zygotic genome activation.","method":"Immunofluorescence, morpholino/RNAi knockdown, kinase inhibitor experiments, mRNA stability assays in mouse oocytes","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined loss-of-function phenotype with mechanistic phosphorylation analysis, single lab","pmids":["23136299"],"is_preprint":false},{"year":2014,"finding":"In human/metazoan cells, EDC4 acts as a scaffold that provides separate binding sites for DCP1, DCP2, and XRN1; DCP2 and XRN1 bind simultaneously to the EDC4 C-terminal domain via short linear motifs; DCP1 and DCP2 form direct but weak interactions that are facilitated by EDC4; the NR-loop in DCP1's EVH1 domain is critical for DCP2 activation; EDC4 couples DCP2 activation with XRN1-mediated 5'-to-3' degradation.","method":"Co-immunoprecipitation, pull-down assays, mutagenesis, reporter mRNA decay assays in human cells","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, mutagenesis, and functional reporter assays, multiple orthogonal methods","pmids":["24510189"],"is_preprint":false},{"year":2015,"finding":"The Dcp2 C-terminal domain contains distinct conserved negative and positive regulatory elements; a single negative element inhibits enzymatic activity and controls downstream functions; positive elements recruit decapping activators Edc3, Pat1, and Upf1 to form distinct decapping complexes controlling substrate specificity.","method":"Genetic analysis of Dcp2 C-terminal deletion/mutation series in S. cerevisiae, mRNA decay assays","journal":"RNA (New York, N.Y.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic genetic approach with defined functional readouts, single lab","pmids":["26184073"],"is_preprint":false},{"year":2015,"finding":"Human Dcp2 levels and activity are controlled by competition between decapping complex assembly and ubiquitin-mediated proteasomal degradation; the Dcp2 C-terminal regulatory domain promotes activation via Hedls (EDC4) binding on one hand, and targets uncomplexed Dcp2 for proteasomal degradation on the other.","method":"Ubiquitin pathway inhibitors, co-immunoprecipitation, protein stability assays, mutagenesis in human cells","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined PTM pathway (ubiquitination) with functional consequence, multiple readouts, single lab","pmids":["25870104"],"is_preprint":false},{"year":2016,"finding":"Crystal structure (1.6 Å) of S. pombe Dcp2-Dcp1 in activated conformation stabilized by an intrinsically disordered Edc1 peptide; an unforeseen rotation of the Dcp2 catalytic domain allows residues from both Dcp2 and Dcp1 to cooperate in RNA binding; this explains decapping activation by increased substrate affinity.","method":"X-ray crystallography (1.6 Å), mutagenesis, enzyme activity assays","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structure with functional mutagenesis validation","pmids":["27183195"],"is_preprint":false},{"year":2016,"finding":"Crystal structure (2.6 Å) of fission yeast Dcp2-Dcp1-PNRC2 heterotrimer with cap analog reveals a composite nucleotide-binding site formed by conserved residues from both Dcp2 catalytic and regulatory domains; cap binding is accompanied by a conformational change in Dcp2; PNRC2 (a short linear motif coactivator) enhances both substrate affinity and the catalytic step.","method":"X-ray crystallography (2.6 Å), enzyme kinetics, mutagenesis","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure combined with kinetic analysis and mutagenesis","pmids":["27694842"],"is_preprint":false},{"year":2016,"finding":"Crystal structure of the active form of yeast Dcp1-Dcp2 bound to the reaction product m7GDP and activator Edc3 (K. lactis); provides structural explanation for substrate binding and Edc3-mediated Dcp2 activation.","method":"X-ray crystallography, enzyme activity assays","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure of active enzyme-product complex with activator","pmids":["27694841"],"is_preprint":false},{"year":2017,"finding":"Methyl TROSY NMR demonstrates that Dcp2 in solution adopts three domain orientations (open, closed, catalytically active); mRNA substrate, Dcp1, and Edc1 shift dynamic equilibria toward the active state; the active state is only stably formed in the presence of both activators and mRNA substrate or m7GDP product; crystal structure of Dcp1:Dcp2:Edc1:m7GDP complex confirmed active state.","method":"Methyl TROSY NMR spectroscopy, X-ray crystallography, enzyme kinetics","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — NMR dynamics with crystal structure and kinetics, multiple orthogonal methods","pmids":["28533364"],"is_preprint":false},{"year":2017,"finding":"Yeast Pat1 C-terminal domain interacts with multiple short HLMs (helical leucine-rich motifs) in the Dcp2 C-terminal region; crystal structures reveal the basis for HLM recognition; Pat1 also interacts with an HLM in Xrn1; Pat1 ability to bind HLMs is required for efficient growth and normal mRNA decay.","method":"X-ray crystallography of Pat1-HLM complexes, pull-down assays, mRNA decay assays, yeast genetics","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with mutagenesis and functional validation","pmids":["29078363"],"is_preprint":false},{"year":2018,"finding":"Crystal structure (2.84 Å) of K. lactis Dcp1-Dcp2 with coactivators Edc1 and Edc3 and substrate analog in active site; Edc1 forms a three-way interface bridging Dcp2 domains to consolidate the active conformation; Dcp2 has selectivity for the first transcribed nucleotide during catalysis; Edc1 and Edc3 can simultaneously activate decapping.","method":"X-ray crystallography (2.84 Å), enzyme kinetics, mutagenesis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure of heterotetrameric complex with substrate analog plus kinetic validation","pmids":["29559651"],"is_preprint":false},{"year":2018,"finding":"Yeast Scd6 activates Dcp2-mediated mRNA decapping and mRNA turnover through its LSm domain in vivo; in a dcp2Δ mutant, tethered Scd6 represses translation without reducing mRNA abundance; in a dcp2Δ dhh1Δ double mutant, Scd6 has no impact on mRNA or protein levels; Scd6 and Dhh1 cooperate in translational repression and mRNA turnover of specific native mRNAs.","method":"Tethering assay, genetic epistasis (dcp2Δ, dhh1Δ), ribosome profiling, RNA-Seq","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis with multiple deletion combinations, ribosome profiling, RNA-seq, multiple orthogonal methods","pmids":["30532217"],"is_preprint":false},{"year":2020,"finding":"Yeast Pby1 directly binds the Dcp1-Dcp2 decapping complex through its C-terminal domain; crystal structure of Pby1-C-terminal domain bound to Dcp1-Dcp2-Edc3 complex is solved; Pby1 binding requires direct interaction with the decapping enzyme for P-body recruitment; Pby1 binding stimulates growth under conditions of compromised decapping activation.","method":"X-ray crystallography, pull-down assays, P-body fluorescence microscopy, yeast growth assays, mutagenesis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with functional mutagenesis and cell biology validation","pmids":["32396195"],"is_preprint":false},{"year":2020,"finding":"P-body enrichment is the strongest correlate of Dcp2-dependent decay in human cells; m6A modification has an additive effect with P-body enrichment for Dcp2 targeting; global profiling in Dcp2 knockout cells via TimeLapse-seq identified the human Dcp2 regulome.","method":"TimeLapse-seq in Dcp2 knockout human cells, bioinformatic correlation analysis","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — clean KO with transcriptome-wide readout but correlative mechanistic inference, single lab","pmids":["32365300"],"is_preprint":false},{"year":2020,"finding":"A bicyclic peptide inhibitor (CP21) selectively binds human DCP2 and inhibits its decapping activity toward selected RNA substrates in human cells; DCP2 inhibition increases P-body formation similar to DCP2 deletion; CP21 enabled identification of 76 previously unreported DCP2 substrates.","method":"Phage display selection, biochemical binding assays, cell-based RNA stability assays, P-body fluorescence microscopy","journal":"Cell chemical biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — selective chemical inhibitor with cellular validation, multiple readouts, single lab","pmids":["33357462"],"is_preprint":false},{"year":2022,"finding":"Yeast Dcp2 C-terminal domain cis-regulatory elements control decapping target specificity: two Upf1-binding motifs direct the enzyme to NMD substrates; a single Edc3-binding motif targets Edc3 and Dhh1 substrates; Pat1-binding leucine-rich motifs target Edc3/Dhh1 substrates under selective conditions; Scd6 and Xrn1 also have specific binding sites on Dcp2.","method":"Extensive genetic and mutational analysis in S. cerevisiae, mRNA decay assays, epistasis analysis","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — extensive genetic epistasis with multiple binding motif mutations and functional mRNA decay readouts","pmids":["35604319"],"is_preprint":false},{"year":2022,"finding":"Human DCP2 and tristetraprolin (TTP) interact directly via their intrinsically disordered regions (IDRs); this interaction impacts ARE-mRNA stability; the DCP2 IDR has a propensity for oligomerization and liquid-liquid phase separation in vitro; TTP partitions into DCP2 phase-separated droplets, suggesting molecular crowding facilitates assembly of a decapping-competent complex.","method":"Pull-down assays, in vitro phase separation assays, mass spectrometry (Urlaub), mRNA stability assays","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding assay plus in vitro phase separation plus cellular mRNA stability, single lab","pmids":["36130271"],"is_preprint":false},{"year":2023,"finding":"MOV10 recruits DCP2 to LINE-1 RNA, forming a MOV10-DCP2-LINE-1 RNP complex with liquid-liquid phase separation properties; DCP2 cooperates with MOV10 to decap LINE-1 RNA, causing LINE-1 RNA degradation and reducing retrotransposition.","method":"Co-immunoprecipitation, in vitro phase separation assays, LINE-1 retrotransposition reporter assays, DCP2 overexpression/knockdown","journal":"EMBO reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP demonstrating complex formation, functional retrotransposition assay, single lab","pmids":["37437058"],"is_preprint":false},{"year":2008,"finding":"SSA/Ro52 autoantigen binds human DCP2 at both its N- and C-termini and co-localizes with DCP2 in P-bodies; Ro52 enhances DCP2 decapping activity in a dose-dependent manner.","method":"Co-immunoprecipitation, in vitro decapping assay, immunofluorescence co-localization","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP and single in vitro assay, single lab, limited follow-up","pmids":["18361920"],"is_preprint":false},{"year":2025,"finding":"Distinct domains of yeast Upf1 make direct contacts with Dcp1/Dcp2, Nmd4, and Ebs1 in the NMD decapping complex; Dcp2 and Upf2 compete for the same binding site on the N-terminal CH domain of Upf1, explaining two mutually exclusive Upf1-containing complexes; Nmd4-assisted recruitment of Upf1 promotes anchoring of the decapping enzyme to NMD target mRNAs.","method":"Recombinant protein interaction assays, pull-down with purified components, competition assays","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — recombinant protein direct binding assays with competition, single lab","pmids":["40071934"],"is_preprint":false},{"year":2025,"finding":"In vitro, eIF4E does not interfere with DCP2 decapping function (negative result contradicting prior models); eIF4E binding increases the affinity of Dcp2 for RNA; DCP2 binds RNA with nanomolar affinity as measured by biophysical assays.","method":"Purified recombinant proteins, biophysical binding assays, in vitro decapping assays","journal":"PloS one","confidence":"Low","confidence_rationale":"Tier 1 / Weak — in vitro reconstitution but limited to in vitro conditions, single lab, no cellular validation","pmids":["40748882"],"is_preprint":false}],"current_model":"DCP2 is the catalytic subunit of the mRNA decapping complex whose Nudix/MutT domain hydrolyzes the m7GpppN 5' cap to generate m7GDP and a 5'-monophosphorylated RNA substrate for XRN1; its activity is governed by conformational equilibrium between open, closed, and catalytically active states that is promoted by direct binding of Dcp1 (via an EVH1-mediated interaction), coactivators Edc1/Edc2 (which bind Dcp1's EVH1 proline-recognition surface), and Edc3 or Scd6 (which bind helical leucine-rich motifs in the Dcp2 C-terminal domain); in metazoans, EDC4/Hedls serves as a scaffold that simultaneously recruits DCP1, DCP2, and XRN1 to couple decapping with downstream degradation; the large, intrinsically disordered Dcp2 C-terminal extension contains cis-regulatory elements that recruit distinct activator complexes (Edc3, Pat1, Upf1, Scd6, Xrn1) to confer substrate specificity toward NMD substrates, ARE-mRNAs, and other transcript classes, while phosphorylation of Dcp2 by Ste20 and ubiquitin-mediated proteasomal degradation of uncomplexed Dcp2 provide additional post-translational regulatory control of decapping activity."},"narrative":{"mechanistic_narrative":"DCP2 is the catalytic subunit of the eukaryotic mRNA decapping enzyme, hydrolyzing the m7GpppN 5' cap of target mRNAs through its MutT/Nudix domain to produce m7GDP and a 5'-monophosphorylated RNA, thereby committing transcripts to 5'-to-3' degradation and serving as a central node in cytoplasmic mRNA turnover [PMID:10508173, PMID:12486012]. Catalysis requires a metal ion coordinated by active-site residues that perform acid/base chemistry, with a metal-binding loop that rearranges during the catalytic cycle [PMID:23911090]. Decapping is governed by a conformational equilibrium in which DCP2 samples open, closed, and catalytically active states; a conserved gatekeeper tryptophan controls the open-to-closed transition, and mRNA substrate together with the obligate partner DCP1 shifts the equilibrium toward the active conformation, in which residues from both DCP2 and DCP1 cooperate to bind RNA and raise substrate affinity [PMID:18280239, PMID:22323607, PMID:27183195, PMID:28533364]. The intrinsically disordered DCP2 C-terminal extension carries both an autoinhibitory negative element and an array of positive cis-regulatory motifs—including helical leucine-rich motifs and dedicated binding sites—that recruit coactivators Edc1/Edc2, Edc3, Scd6, Pat1, and Upf1 to assemble distinct decapping complexes conferring substrate specificity toward NMD substrates and other transcript classes [PMID:21148770, PMID:22085934, PMID:26184073, PMID:29078363, PMID:35604319]. In metazoans EDC4 (Hedls) acts as a scaffold that simultaneously binds DCP1, DCP2, and XRN1 to couple decapping with downstream exonucleolytic degradation, while uncomplexed DCP2 is targeted for ubiquitin-mediated proteasomal degradation [PMID:24510189, PMID:25870104]. DCP2 localizes to and is required for P-bodies, and P-body enrichment is the strongest correlate of DCP2-dependent decay in human cells [PMID:16177138, PMID:22085934, PMID:32365300]. Beyond bulk turnover, DCP2 substrate selection is shaped by 5'-proximal stem-loop structure and the identity of the first transcribed nucleotide, and DCP2 executes regulated decay in miRNA-mediated silencing, innate antiviral responses, oocyte maternal mRNA clearance, and restriction of LINE-1 retrotransposition [PMID:19233875, PMID:16815998, PMID:22252322, PMID:23824541, PMID:23136299, PMID:37437058]. Phosphorylation of DCP2 by Ste20 during stress modulates its interactions and P-body accumulation, adding post-translational control [PMID:20513766].","teleology":[{"year":1999,"claim":"Establishing that DCP2 is genetically required for decapping and that its Nudix motif is essential answered whether a dedicated enzyme drives cap removal in vivo.","evidence":"Genetic suppressor screen, Co-IP with Dcp1, and in vivo decay assays in yeast","pmids":["10508173"],"confidence":"High","gaps":["Did not establish whether Dcp2 is itself the catalytic hydrolase or an essential cofactor","Nature of the Dcp1-Dcp2 interaction (direct vs indirect) left open"]},{"year":2002,"claim":"Reconstitution of human DCP2 as the catalytically active enzyme producing m7GDP defined DCP2 as the decapping catalyst and showed conservation and P-body localization.","evidence":"Recombinant protein, in vitro decapping assay, mutagenesis, immunofluorescence co-localization with hDcp1","pmids":["12486012"],"confidence":"High","gaps":["Mechanism of cap recognition and the structural basis of catalysis unresolved","How DCP1 contributes to activity not yet defined"]},{"year":2005,"claim":"Loss-of-function in Drosophila placed the DCP1:DCP2 complex downstream of miRNA-directed and CCR4:NOT-coupled mRNA decay, connecting decapping to regulated silencing pathways.","evidence":"RNAi depletion, reporter mRNA stability and polysome analyses in S2 cells","pmids":["16177138","16815998"],"confidence":"Medium","gaps":["Did not establish whether DCP2 acts directly on silenced transcripts or downstream of deadenylation","Distinction between decay and translational repression only partially separated"]},{"year":2005,"claim":"In vitro substrate studies showed DCP2 acts on diverse caps (including trimethylguanosine) and is sensitive to 5'-end sequence/structure, beginning to define substrate determinants.","evidence":"In vitro decapping with cap analogs and competing RNA across three species","pmids":["16199859"],"confidence":"High","gaps":["Physiological relevance of TMG decapping in cells not established","Structural basis for 5'-context sensitivity unknown at this stage"]},{"year":2008,"claim":"Structural and NMR analyses revealed the bipartite RNA-binding channel and open/closed conformations, establishing that DCP1 stimulates catalysis by stabilizing the closed conformation rather than directly contacting the cap.","evidence":"X-ray crystallography of S. pombe Dcp1-Dcp2, SAXS, NMR, kinetics, mutagenesis","pmids":["18280238","18280239"],"confidence":"High","gaps":["Atomic geometry of the fully active catalytic state not yet captured","How coactivators beyond Dcp1 reshape the equilibrium unknown"]},{"year":2007,"claim":"Demonstration of transcript-specific decapping (Rrp41 5' element) showed DCP2 selectivity confers regulation of individual mRNAs, not just bulk turnover.","evidence":"RNA immunoprecipitation, in vitro decapping, RNAi with mRNA stability measurement","pmids":["18039849"],"confidence":"Medium","gaps":["Generality of intrinsic sequence-directed selectivity across the transcriptome not tested","Single lab"]},{"year":2009,"claim":"Identification of 5'-proximal stem-loops as enhancers of DCP2 decapping clarified that secondary structure, not primary sequence, is a key intrinsic substrate determinant.","evidence":"In vitro decapping and transfection assays with RNA secondary-structure mutants","pmids":["19233875"],"confidence":"Medium","gaps":["Structural mechanism by which DCP2 recognizes stem-loops not resolved","Single lab"]},{"year":2010,"claim":"Defining Edc1/Edc2, Edc3, and Ste20-phosphorylation inputs established that coactivators and PTMs tune DCP2 activity, P-body recruitment, and substrate-specific decay.","evidence":"Kinetics and mutagenesis (Edc1/Edc2 via Dcp1 EVH1; 1000-fold stimulation), Edc3 peptide-binding mapping, Ste20 kinase assays and P-body microscopy in yeast","pmids":["21148770","20086104","20513766"],"confidence":"High","gaps":["How distinct coactivators are selected for particular substrates not yet defined","In vivo writer/eraser dynamics of S137 phosphorylation incomplete"]},{"year":2011,"claim":"The Edc3 LSm–HLM crystal structure showed that multiple helical leucine-rich motifs in the DCP2 C-terminal extension recruit Edc3/Scd6 and are required for P-body localization, defining the C-terminal IDR as a modular activator-docking platform.","evidence":"X-ray crystallography, in vitro decapping, P-body microscopy, mutagenesis in yeast","pmids":["22085934"],"confidence":"High","gaps":["Functional division of labor among the multiple HLMs not yet mapped","Competition between Edc3 and Scd6 in vivo consequences unclear at this stage"]},{"year":2012,"claim":"A conserved gatekeeper tryptophan was shown to govern conformational dynamics, mechanistically linking domain motion to coactivation by Edc1.","evidence":"NMR dynamics, kinetics, mutagenesis in S. pombe Dcp2","pmids":["22323607"],"confidence":"High","gaps":["Quantitative populations of conformational states in the catalytic cycle not fully defined here"]},{"year":2012,"claim":"Cellular studies extended DCP2 function to regulated programs—innate immunity (IRF-7 mRNA stability) and viral restriction (oocyte/embryo context follows)—showing decapping shapes biological responses.","evidence":"Dcp2 hypomorphic mouse cells, mRNA stability assays, RT-PCR, immunoblot","pmids":["22252322"],"confidence":"Medium","gaps":["Whether IRF-7 is a direct DCP2 substrate not definitively shown","Single lab"]},{"year":2013,"claim":"Catalytic-domain structures and kinetics defined the essential metal ion, active-site acid/base residues, and a mobile metal-binding loop, providing the chemical mechanism of cap hydrolysis.","evidence":"X-ray crystallography, kinetics/mutagenesis, NMR, molecular dynamics","pmids":["23911090"],"confidence":"High","gaps":["Coupling between catalytic-domain chemistry and global conformational activation not fully integrated here"]},{"year":2013,"claim":"Genetic/functional studies placed DCP2 in antiviral defense against bunyaviruses and in maternal mRNA clearance during oocyte maturation, broadening its physiological repertoire.","evidence":"Genome-wide RNAi screen, RNA-seq and cap-snatching analysis in Drosophila; knockdown and kinase-inhibitor experiments in mouse oocytes","pmids":["23824541","23136299"],"confidence":"Medium","gaps":["Mechanism linking decapping to suppression of viral transcription incompletely defined","Direct DCP2 substrates during oocyte maturation not enumerated"]},{"year":2016,"claim":"High-resolution structures of activated Dcp1-Dcp2 with Edc1, PNRC2, Edc3, and cap analog/product captured the catalytically active conformation, showing a catalytic-domain rotation that forms a composite cap/RNA-binding site and explains activation via increased substrate affinity.","evidence":"Multiple X-ray structures (1.6–2.84 Å) with kinetics and mutagenesis across fission/budding yeast","pmids":["27183195","27694842","27694841","29559651"],"confidence":"High","gaps":["Solution populations of the active state still required orthogonal validation (addressed 2017)","Generalization of short-linear-motif coactivation to metazoan DCP2 not structurally shown"]},{"year":2017,"claim":"Methyl-TROSY NMR resolved three solution conformations and showed the active state forms only with both activators and substrate/product, completing the dynamic model of conformational selection.","evidence":"Methyl TROSY NMR, crystallography of Dcp1:Dcp2:Edc1:m7GDP, kinetics","pmids":["28533364"],"confidence":"High","gaps":["How phosphorylation or scaffolds modulate this equilibrium in cells untested here"]},{"year":2017,"claim":"Defining Pat1 and Scd6 recognition of DCP2 HLMs, and Scd6/Dhh1 cooperation, clarified how distinct activators dock to the C-terminal IDR and couple translational repression with turnover.","evidence":"Crystallography of Pat1-HLM complexes; tethering, epistasis, ribosome profiling and RNA-seq for Scd6","pmids":["29078363","30532217"],"confidence":"High","gaps":["Combinatorial logic of simultaneous activator occupancy on a single DCP2 not fully resolved"]},{"year":2015,"claim":"Identification of negative and positive cis-regulatory elements in the DCP2 C-terminal domain, and competition between EDC4-mediated assembly and ubiquitin-driven degradation, established autoinhibition and protein-level control of decapping.","evidence":"Genetic deletion/mutation series in yeast; ubiquitin inhibitors, Co-IP, protein-stability assays in human cells","pmids":["26184073","20104"],"confidence":"Medium","gaps":["E3 ligase targeting uncomplexed DCP2 not identified","Single lab for each system"]},{"year":2018,"claim":"EDC4/Hedls was defined as a metazoan scaffold providing separate binding sites for DCP1, DCP2, and XRN1, physically coupling decapping to 5'-to-3' degradation.","evidence":"Reciprocal Co-IP, pull-downs, mutagenesis, reporter decay assays in human cells","pmids":["24510189"],"confidence":"High","gaps":["Stoichiometry and structural architecture of the full EDC4-bridged assembly unresolved"]},{"year":2020,"claim":"Transcriptome-wide profiling and a selective chemical inhibitor defined the human DCP2 regulome, showing P-body enrichment as the strongest correlate of DCP2-dependent decay and identifying new substrates.","evidence":"TimeLapse-seq in DCP2-KO human cells; bicyclic peptide inhibitor (CP21) with cellular RNA-stability and P-body assays; Pby1 structure for P-body recruitment","pmids":["32365300","33357462","32396195"],"confidence":"Medium","gaps":["Causality between P-body partitioning and decay vs correlation unresolved","Direct vs indirect status of many inhibitor-revealed substrates not validated"]},{"year":2022,"claim":"Phase-separation and IDR-interaction studies (TTP, and Upf1/NMD-substrate targeting motifs) connected DCP2 condensate behavior and C-terminal cis-elements to substrate-class-specific decay.","evidence":"Pull-downs, in vitro phase separation, mRNA stability for TTP; extensive genetic/epistasis mapping of Upf1/Edc3/Pat1/Scd6/Xrn1 motifs in yeast","pmids":["36130271","35604319"],"confidence":"Medium","gaps":["In vivo requirement of phase separation for catalysis not established","Quantitative contribution of each motif to specificity incomplete"]},{"year":2023,"claim":"MOV10-directed recruitment of DCP2 to LINE-1 RNA showed DCP2 can be targeted by RNA-binding adaptors to restrict retrotransposition via decapping within phase-separated RNPs.","evidence":"Co-IP, in vitro phase separation, LINE-1 retrotransposition reporter assays with DCP2 perturbation","pmids":["37437058"],"confidence":"Medium","gaps":["Direct decapping of LINE-1 RNA by DCP2 vs indirect effects not fully separated","Single lab"]},{"year":2025,"claim":"Mapping of Upf1 contacts and the Upf1/Upf2 competition at the CH domain refined how the NMD decapping complex is assembled and anchored to target mRNAs.","evidence":"Recombinant protein interaction and competition assays with purified components","pmids":["40071934"],"confidence":"Medium","gaps":["Structural model of the full Upf1-anchored decapping complex not determined","In vivo ordering of assembly events not established"]},{"year":null,"claim":"How DCP2 condensate/phase-separation behavior, conformational dynamics, PTMs, and combinatorial coactivator occupancy are integrated in living cells to select specific substrates remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No in-cell measurement linking conformational state to substrate choice","E3 ligase and full PTM code controlling DCP2 abundance unknown","Causal role of P-body/condensate partitioning in catalysis untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[0,1,3,15]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[1,15,22]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[5,6,8,36]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1]}],"pathway":[{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[0,1,4,31]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[14,16]}],"complexes":["DCP1-DCP2 decapping complex","P-body","EDC4 (Hedls) decapping/XRN1 scaffold complex","Upf1-containing NMD decapping complex"],"partners":["DCP1","EDC3","EDC4","PAT1","UPF1","SCD6","XRN1","MOV10"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8IU60","full_name":"m7GpppN-mRNA hydrolase","aliases":["Nucleoside diphosphate-linked moiety X motif 20","Nudix motif 20","mRNA-decapping enzyme 2","hDpc"],"length_aa":420,"mass_kda":48.4,"function":"Decapping metalloenzyme that catalyzes the cleavage of the cap structure on mRNAs (PubMed:12218187, PubMed:12417715, PubMed:12923261, PubMed:21070968, PubMed:28002401, PubMed:31875550). Removes the 7-methyl guanine cap structure from mRNA molecules, yielding a 5'-phosphorylated mRNA fragment and 7m-GDP (PubMed:12486012, PubMed:12923261, PubMed:21070968, PubMed:28002401, PubMed:31875550). Necessary for the degradation of mRNAs, both in normal mRNA turnover and in nonsense-mediated mRNA decay (PubMed:14527413). Plays a role in replication-dependent histone mRNA degradation (PubMed:18172165). Has higher activity towards mRNAs that lack a poly(A) tail (PubMed:21070968). Has no activity towards a cap structure lacking an RNA moiety (PubMed:21070968). The presence of a N(6)-methyladenosine methylation at the second transcribed position of mRNAs (N(6),2'-O-dimethyladenosine cap; m6A(m)) provides resistance to DCP2-mediated decapping (PubMed:28002401). Blocks autophagy in nutrient-rich conditions by repressing the expression of ATG-related genes through degradation of their transcripts (PubMed:26098573)","subcellular_location":"Cytoplasm, P-body; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q8IU60/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DCP2","classification":"Not Classified","n_dependent_lines":159,"n_total_lines":1208,"dependency_fraction":0.1316225165562914},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000172795","cell_line_id":"CID000836","localizations":[{"compartment":"vesicles","grade":3}],"interactors":[{"gene":"ARHGAP18","stoichiometry":0.2},{"gene":"CLTA","stoichiometry":0.2},{"gene":"CLTB","stoichiometry":0.2},{"gene":"EDC4","stoichiometry":0.2},{"gene":"HNRNPA2B1","stoichiometry":0.2},{"gene":"UBE2M","stoichiometry":0.2},{"gene":"VPS35","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000836","total_profiled":1310},"omim":[{"mim_id":"617071","title":"LONG NONCODING RNA 13","url":"https://www.omim.org/entry/617071"},{"mim_id":"616460","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 50; MRT50","url":"https://www.omim.org/entry/616460"},{"mim_id":"612006","title":"CELIAC DISEASE, SUSCEPTIBILITY TO, 8; CELIAC8","url":"https://www.omim.org/entry/612006"},{"mim_id":"610966","title":"FTO ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE; FTO","url":"https://www.omim.org/entry/610966"},{"mim_id":"610739","title":"TRINUCLEOTIDE REPEAT-CONTAINING GENE 6A; TNRC6A","url":"https://www.omim.org/entry/610739"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cytoplasmic bodies","reliability":"Approved"},{"location":"Cell Junctions","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DCP2"},"hgnc":{"alias_symbol":["NUDT20"],"prev_symbol":[]},"alphafold":{"accession":"Q8IU60","domains":[{"cath_id":"1.10.10.1050","chopping":"11-94","consensus_level":"high","plddt":87.645,"start":11,"end":94},{"cath_id":"3.90.79.10","chopping":"98-243","consensus_level":"high","plddt":91.4986,"start":98,"end":243}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IU60","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IU60-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IU60-F1-predicted_aligned_error_v6.png","plddt_mean":66.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DCP2","jax_strain_url":"https://www.jax.org/strain/search?query=DCP2"},"sequence":{"accession":"Q8IU60","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8IU60.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8IU60/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IU60"}},"corpus_meta":[{"pmid":"16815998","id":"PMC_16815998","title":"mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes.","date":"2006","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/16815998","citation_count":737,"is_preprint":false},{"pmid":"12486012","id":"PMC_12486012","title":"Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12486012","citation_count":400,"is_preprint":false},{"pmid":"16177138","id":"PMC_16177138","title":"A crucial role for GW182 and the DCP1:DCP2 decapping complex in miRNA-mediated gene silencing.","date":"2005","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/16177138","citation_count":368,"is_preprint":false},{"pmid":"10508173","id":"PMC_10508173","title":"The DCP2 protein is required for mRNA decapping in Saccharomyces cerevisiae and contains a functional MutT motif.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10508173","citation_count":284,"is_preprint":false},{"pmid":"18280239","id":"PMC_18280239","title":"Structural basis of dcp2 recognition and activation by dcp1.","date":"2008","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/18280239","citation_count":116,"is_preprint":false},{"pmid":"24510189","id":"PMC_24510189","title":"The activation of the decapping enzyme DCP2 by DCP1 occurs on the EDC4 scaffold and involves a conserved loop in DCP1.","date":"2014","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/24510189","citation_count":102,"is_preprint":false},{"pmid":"22085934","id":"PMC_22085934","title":"The structural basis of Edc3- and Scd6-mediated activation of the Dcp1:Dcp2 mRNA decapping complex.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22085934","citation_count":101,"is_preprint":false},{"pmid":"18280238","id":"PMC_18280238","title":"mRNA decapping is promoted by an RNA-binding channel in Dcp2.","date":"2008","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/18280238","citation_count":86,"is_preprint":false},{"pmid":"23824541","id":"PMC_23824541","title":"A genome-wide RNAi screen reveals that mRNA decapping restricts bunyaviral replication by limiting the pools of Dcp2-accessible targets for cap-snatching.","date":"2013","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/23824541","citation_count":82,"is_preprint":false},{"pmid":"20513766","id":"PMC_20513766","title":"Dcp2 phosphorylation by Ste20 modulates stress granule assembly and mRNA decay in Saccharomyces cerevisiae.","date":"2010","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/20513766","citation_count":81,"is_preprint":false},{"pmid":"23136299","id":"PMC_23136299","title":"Maternally recruited DCP1A and DCP2 contribute to messenger RNA degradation during oocyte maturation and genome activation in mouse.","date":"2013","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/23136299","citation_count":66,"is_preprint":false},{"pmid":"16207815","id":"PMC_16207815","title":"Caenorhabditis elegans decapping proteins: localization and functional analysis of Dcp1, Dcp2, and DcpS during embryogenesis.","date":"2005","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/16207815","citation_count":57,"is_preprint":false},{"pmid":"18039849","id":"PMC_18039849","title":"Transcript-specific decapping and regulated stability by the human Dcp2 decapping protein.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18039849","citation_count":55,"is_preprint":false},{"pmid":"20086104","id":"PMC_20086104","title":"Identification and analysis of the interaction between Edc3 and Dcp2 in Saccharomyces cerevisiae.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20086104","citation_count":49,"is_preprint":false},{"pmid":"26184073","id":"PMC_26184073","title":"Control of mRNA decapping by positive and negative regulatory elements in the Dcp2 C-terminal domain.","date":"2015","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/26184073","citation_count":46,"is_preprint":false},{"pmid":"27183195","id":"PMC_27183195","title":"Structure of the Dcp2-Dcp1 mRNA-decapping complex in the activated conformation.","date":"2016","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27183195","citation_count":45,"is_preprint":false},{"pmid":"21148770","id":"PMC_21148770","title":"Dcp1 links coactivators of mRNA decapping to Dcp2 by proline recognition.","date":"2010","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/21148770","citation_count":45,"is_preprint":false},{"pmid":"27694842","id":"PMC_27694842","title":"Structural basis of mRNA-cap recognition by Dcp1-Dcp2.","date":"2016","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27694842","citation_count":44,"is_preprint":false},{"pmid":"16199859","id":"PMC_16199859","title":"Dcp2 Decaps m2,2,7GpppN-capped RNAs, and its activity is sequence and context dependent.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16199859","citation_count":42,"is_preprint":false},{"pmid":"27694841","id":"PMC_27694841","title":"Structure of the active form of Dcp1-Dcp2 decapping enzyme bound to m7GDP and its Edc3 activator.","date":"2016","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27694841","citation_count":42,"is_preprint":false},{"pmid":"29078363","id":"PMC_29078363","title":"A unique surface on Pat1 C-terminal domain directly interacts with Dcp2 decapping enzyme and Xrn1 5'-3' mRNA exonuclease in yeast.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29078363","citation_count":42,"is_preprint":false},{"pmid":"28533364","id":"PMC_28533364","title":"Changes in conformational equilibria regulate the activity of the Dcp2 decapping enzyme.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28533364","citation_count":39,"is_preprint":false},{"pmid":"29559651","id":"PMC_29559651","title":"Structure of the activated Edc1-Dcp1-Dcp2-Edc3 mRNA decapping complex with substrate analog poised for catalysis.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29559651","citation_count":36,"is_preprint":false},{"pmid":"22252322","id":"PMC_22252322","title":"Dcp2 decapping protein modulates mRNA stability of the critical interferon regulatory factor (IRF) IRF-7.","date":"2012","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22252322","citation_count":35,"is_preprint":false},{"pmid":"31473440","id":"PMC_31473440","title":"Dcp2: an mRNA decapping enzyme that adopts many different shapes and forms.","date":"2019","source":"Current opinion in structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/31473440","citation_count":32,"is_preprint":false},{"pmid":"30532217","id":"PMC_30532217","title":"Conserved mRNA-granule component Scd6 targets Dhh1 to repress translation initiation and activates Dcp2-mediated mRNA decay in vivo.","date":"2018","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30532217","citation_count":32,"is_preprint":false},{"pmid":"22323607","id":"PMC_22323607","title":"Interdomain dynamics and coactivation of the mRNA decapping enzyme Dcp2 are mediated by a gatekeeper tryptophan.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22323607","citation_count":30,"is_preprint":false},{"pmid":"32365300","id":"PMC_32365300","title":"Global Profiling of Cellular Substrates of Human Dcp2.","date":"2020","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32365300","citation_count":27,"is_preprint":false},{"pmid":"19233875","id":"PMC_19233875","title":"Mutational analysis of a Dcp2-binding element reveals general enhancement of decapping by 5'-end stem-loop structures.","date":"2009","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/19233875","citation_count":25,"is_preprint":false},{"pmid":"25870104","id":"PMC_25870104","title":"Competition between Decapping Complex Formation and Ubiquitin-Mediated Proteasomal Degradation Controls Human Dcp2 Decapping Activity.","date":"2015","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25870104","citation_count":22,"is_preprint":false},{"pmid":"23911090","id":"PMC_23911090","title":"Active site conformational dynamics are coupled to catalysis in the mRNA decapping enzyme Dcp2.","date":"2013","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/23911090","citation_count":22,"is_preprint":false},{"pmid":"35604319","id":"PMC_35604319","title":"Dcp2 C-terminal cis-binding elements control selective targeting of the decapping enzyme by forming distinct decapping complexes.","date":"2022","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/35604319","citation_count":18,"is_preprint":false},{"pmid":"33357462","id":"PMC_33357462","title":"Discovery of cellular substrates of human RNA-decapping enzyme DCP2 using a stapled bicyclic peptide inhibitor.","date":"2020","source":"Cell chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/33357462","citation_count":15,"is_preprint":false},{"pmid":"37266577","id":"PMC_37266577","title":"Decapping factor Dcp2 controls mRNA abundance and translation to adjust metabolism and filamentation to nutrient availability.","date":"2023","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/37266577","citation_count":12,"is_preprint":false},{"pmid":"37437058","id":"PMC_37437058","title":"MOV10 recruits DCP2 to decap human LINE-1 RNA by forming large cytoplasmic granules with phase separation properties.","date":"2023","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/37437058","citation_count":11,"is_preprint":false},{"pmid":"18971632","id":"PMC_18971632","title":"Control of mRNA decapping by Dcp2: An open and shut case?","date":"2008","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/18971632","citation_count":11,"is_preprint":false},{"pmid":"29101277","id":"PMC_29101277","title":"Application of a Schizosaccharomyces pombe Edc1-fused Dcp1-Dcp2 decapping enzyme for transcription start site mapping.","date":"2017","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/29101277","citation_count":10,"is_preprint":false},{"pmid":"36130271","id":"PMC_36130271","title":"Intrinsically disordered regions of tristetraprolin and DCP2 directly interact to mediate decay of ARE-mRNA.","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/36130271","citation_count":9,"is_preprint":false},{"pmid":"26662055","id":"PMC_26662055","title":"Tob1 is expressed in developing and adult gonads and is associated with the P-body marker, Dcp2.","date":"2015","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/26662055","citation_count":9,"is_preprint":false},{"pmid":"28557307","id":"PMC_28557307","title":"Pervasive yet nonuniform contributions of Dcp2 and Cnot7 to maternal mRNA clearance in zebrafish.","date":"2017","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/28557307","citation_count":9,"is_preprint":false},{"pmid":"32245620","id":"PMC_32245620","title":"Global deletion of the RNA decapping enzyme Dcp2 postnatally in male mice results in infertility.","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/32245620","citation_count":7,"is_preprint":false},{"pmid":"18361920","id":"PMC_18361920","title":"SSA/Ro52 autoantigen interacts with Dcp2 to enhance its decapping activity.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18361920","citation_count":6,"is_preprint":false},{"pmid":"32396195","id":"PMC_32396195","title":"Pby1 is a direct partner of the Dcp2 decapping enzyme.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/32396195","citation_count":4,"is_preprint":false},{"pmid":"29912646","id":"PMC_29912646","title":"MicroRNA-141-3p/200a-3p target and may be involved in post-transcriptional repression of RNA decapping enzyme Dcp2 during renal development.","date":"2018","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29912646","citation_count":4,"is_preprint":false},{"pmid":"40071934","id":"PMC_40071934","title":"RNA anchoring of Upf1 facilitates recruitment of Dcp2 in the NMD decapping complex.","date":"2025","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/40071934","citation_count":3,"is_preprint":false},{"pmid":"31146005","id":"PMC_31146005","title":"Role of DCP1-DCP2 complex regulated by viral and host microRNAs in DNA virus infection.","date":"2019","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31146005","citation_count":3,"is_preprint":false},{"pmid":"34536141","id":"PMC_34536141","title":"The mRNA decapping protein 2 (DCP2) is a major regulator of developmental events in Drosophila-insights from expression paradigms.","date":"2021","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/34536141","citation_count":2,"is_preprint":false},{"pmid":"32591349","id":"PMC_32591349","title":"A Forward Genetic Approach to Mapping a P-Element Second Site Mutation Identifies DCP2 as a Novel Tumor Suppressor in Drosophila melanogaster.","date":"2020","source":"G3 (Bethesda, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/32591349","citation_count":2,"is_preprint":false},{"pmid":"37097350","id":"PMC_37097350","title":"Mechanism of Dcp2/RNCR3/Dkc1/Snora62 axis regulating neuronal apoptosis in chronic cerebral ischemia.","date":"2023","source":"Cell biology and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/37097350","citation_count":1,"is_preprint":false},{"pmid":"36711592","id":"PMC_36711592","title":"Decapping factor Dcp2 controls mRNA abundance and translation to adjust metabolism and filamentation to nutrient availability.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/36711592","citation_count":1,"is_preprint":false},{"pmid":"37024243","id":"PMC_37024243","title":"Disruption of Dcp1 leads to a Dcp2-dependent aberrant ribosome profiles in Aspergillus nidulans.","date":"2023","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/37024243","citation_count":1,"is_preprint":false},{"pmid":"27151193","id":"PMC_27151193","title":"PDZ Binding Domains, Structural Disorder and Phosphorylation: A Menage-a-trois Tailing Dcp2 mRNA Decapping Enzymes.","date":"2016","source":"Protein and peptide letters","url":"https://pubmed.ncbi.nlm.nih.gov/27151193","citation_count":1,"is_preprint":false},{"pmid":"19636815","id":"PMC_19636815","title":"Backbone and sidechain methyl Ile (delta1), Leu and Val resonance assignments of the catalytic domain of the yeast mRNA decapping enzyme, Dcp2.","date":"2007","source":"Biomolecular NMR assignments","url":"https://pubmed.ncbi.nlm.nih.gov/19636815","citation_count":1,"is_preprint":false},{"pmid":"40748882","id":"PMC_40748882","title":"Biochemical analysis of human eIF4E-DCP2 interaction: Implications for the relationship between translation initiation and decapping.","date":"2025","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/40748882","citation_count":0,"is_preprint":false},{"pmid":"41135857","id":"PMC_41135857","title":"Developmental delay in DCP2l(3)tb of Drosophila melanogaster is due to disruption in the regulation of ecdysone signaling.","date":"2025","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/41135857","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.12.18.629111","title":"Mapping interactions within the NMD decapping complex reveals how Upf1 recruits Dcp2 onto mRNA targets","date":"2025-01-04","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.18.629111","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.08.28.610059","title":"Decapping activators Edc3 and Scd6 act redundantly with Dhh1 in post-transcriptional repression of starvation-induced pathways","date":"2024-08-28","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.28.610059","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":25465,"output_tokens":8518,"usd":0.102083,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18299,"output_tokens":6608,"usd":0.128348,"stage2_stop_reason":"end_turn"},"total_usd":0.230431,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Yeast Dcp2 is required for mRNA decapping of both normal mRNAs and NMD substrates; its MutT/Nudix motif is necessary and sufficient for decapping function; Dcp2 co-immunoprecipitates with Dcp1 and is required for production of enzymatically active decapping enzyme, indicating direct or indirect Dcp1-Dcp2 interaction is needed for activity.\",\n      \"method\": \"Genetic suppressor screen, co-immunoprecipitation, mutational analysis, in vivo mRNA decay assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (genetics, Co-IP, mutagenesis, in vivo decay), foundational paper replicated across many subsequent studies\",\n      \"pmids\": [\"10508173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Human Dcp2 (hDcp2) is the catalytically active decapping enzyme; its MutT/Nudix domain mediates activity; it generates m7GDP and 5'-phosphorylated mRNA products; hDcp1 and hDcp2 co-localize in specific cytoplasmic foci (P-bodies); Dcp2 activity is evolutionarily conserved.\",\n      \"method\": \"Recombinant protein expression, in vitro decapping assay, mutational analysis, immunofluorescence co-localization\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro biochemical reconstitution with mutagenesis, direct localization experiments, replicated across species\",\n      \"pmids\": [\"12486012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The DCP1:DCP2 decapping complex is required for miRNA-mediated gene silencing in Drosophila cells; depletion of DCP1 or DCP2 inhibits miRNA-mediated decay of reporter mRNAs.\",\n      \"method\": \"RNAi depletion in Drosophila S2 cells, reporter assays\",\n      \"journal\": \"RNA (New York, N.Y.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean loss-of-function with defined pathway phenotype, single lab\",\n      \"pmids\": [\"16177138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Nematode Dcp2 decaps both m7GpppG- and m2,2,7GpppG (trimethylguanosine)-capped RNAs; Dcp2 activity is influenced by the sequence and structural context of the 5' end of the mRNA substrate; budding yeast and human Dcp2 are also active on trimethylguanosine-capped substrates; Dcp1 does not significantly enhance Dcp2 activity in nematodes.\",\n      \"method\": \"In vitro decapping assays with cap analogs, competing RNA, recombinant proteins\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro biochemical reconstitution across three species with substrate competition assays\",\n      \"pmids\": [\"16199859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"mRNA degradation by miRNAs and GW182 in Drosophila requires both the CCR4:NOT deadenylase complex and the DCP1:DCP2 decapping complex; depletion of DCP1 or DCP2 inhibits mRNA decay but not translational repression by miRNAs.\",\n      \"method\": \"RNAi depletion, reporter mRNA stability assays, polysome analysis in Drosophila S2 cells\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods, replicated across multiple pathway components, well-cited\",\n      \"pmids\": [\"16815998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Human Dcp2 preferentially binds and decaps a subset of mRNAs; a 60-nucleotide element at the 5' terminus of Rrp41 mRNA serves as a specific Dcp2 substrate; reduction of hDcp2 levels selectively stabilizes Rrp41 mRNA in cells, demonstrating transcript-specific regulation.\",\n      \"method\": \"RNA immunoprecipitation, in vitro decapping assays, RNAi knockdown with mRNA stability measurement\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (biochemistry + cell-based), single lab\",\n      \"pmids\": [\"18039849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Yeast Dcp2 uses a bipartite RNA-binding surface forming a channel that intersects the catalytic and Dcp1-binding regulatory domains; cap binding is weak but specific and requires RNA body contact; Dcp1 stimulates the catalytic step of decapping through a substrate-induced conformational change.\",\n      \"method\": \"NMR spectroscopy, enzyme kinetics\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — NMR structural analysis combined with kinetic dissection, multiple orthogonal methods\",\n      \"pmids\": [\"18280238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Crystal structure of S. pombe Dcp1-Dcp2 complex combined with SAXS reveals Dcp2 adopts open and closed conformations; the closed conformation is catalytically more active; a bipartite RNA-binding channel containing the active site is identified; Dcp1 stimulates Dcp2 activity by promoting/stabilizing the closed conformation.\",\n      \"method\": \"X-ray crystallography, SAXS, enzyme activity assays, mutagenesis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with SAXS and mutagenesis, multiple orthogonal methods in one study\",\n      \"pmids\": [\"18280239\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Enhanced decapping by Dcp2 depends on a stem-loop structure within the first 33 nucleotides of target mRNAs, not primary sequence; 5'-proximal stem-loops generally enhance Dcp2-mediated decapping; Dcp2 alone can preferentially associate with and decap stem-loop-containing substrates without additional proteins.\",\n      \"method\": \"In vitro decapping assays, mutational analysis of RNA secondary structure, transfection assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with structured substrate analysis, single lab\",\n      \"pmids\": [\"19233875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Yeast Dcp2 is phosphorylated on serine 137 by the Ste20 kinase during stress; this phosphorylation affects decay of specific mRNAs, is required for Dcp2 accumulation in P-bodies, modulates specific protein interactions of Dcp2, and is required for efficient stress granule formation.\",\n      \"method\": \"In vivo phosphorylation mapping, kinase assays with Ste20, P-body fluorescence microscopy, mRNA decay assays in yeast mutants\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — identified kinase writer, mapped phosphorylation site, multiple functional readouts, direct localization experiments\",\n      \"pmids\": [\"20513766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Edc3 binding to yeast Dcp2 is mediated by a short peptide sequence C-terminal to the catalytic domain of Dcp2; this interaction is required for Edc3 to stimulate Dcp2 decapping activity in vitro, for Dcp2 accumulation in P-bodies, and for efficient degradation of RPS28B mRNA.\",\n      \"method\": \"Mutational analysis, in vitro decapping assays, P-body fluorescence microscopy, mRNA decay assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (biochemistry, cell biology, genetics) defining a specific interaction domain\",\n      \"pmids\": [\"20086104\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Dcp1 couples coactivator binding to Dcp2 activation; Edc1 and Edc2 bind Dcp1 via its EVH1 proline recognition site and stimulate decapping 1000-fold, affecting both substrate KM and catalytic rate; the Dcp1 EVH1 domain or Edc1 proline-rich sequence mutations block stimulation.\",\n      \"method\": \"Enzyme kinetics, mutagenesis, binding assays\",\n      \"journal\": \"RNA (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — quantitative kinetic analysis with mutagenesis defining mechanism\",\n      \"pmids\": [\"21148770\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Crystal structure of yeast Edc3 LSm domain bound to a helical leucine-rich motif (HLM) from Dcp2 reveals the structural basis of interaction; multiple HLMs in the Dcp2 C-terminal extension bind Edc3; Edc3 and related Scd6 compete for the same HLMs on Dcp2; Edc3 and Scd6 stimulate decapping in vitro; C-terminal HLMs are necessary for Dcp1:Dcp2 localization to P-bodies in vivo.\",\n      \"method\": \"X-ray crystallography, in vitro decapping assays, P-body fluorescence microscopy, mutagenesis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with functional validation by in vitro assays and cell biology\",\n      \"pmids\": [\"22085934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Tryptophan 43 of S. pombe Dcp2 is a conserved gatekeeper of the open-to-closed conformational transition; Dcp2 samples multiple conformations on millisecond-microsecond timescales; mutation of this tryptophan abolishes dynamic behavior and attenuates coactivation by Edc1.\",\n      \"method\": \"NMR spectroscopy, enzyme kinetics, mutagenesis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — NMR dynamics combined with mutagenesis and kinetics, multiple orthogonal methods\",\n      \"pmids\": [\"22323607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Mouse Dcp2 modulates IRF-7 mRNA stability; cells with reduced Dcp2 (Dcp2β/β) show increased IRF-7 mRNA and protein due to IRF-7 mRNA stabilization; Dcp2 expression is induced upon viral infection, suggesting a negative feedback role in the innate immune response.\",\n      \"method\": \"Dcp2 hypomorphic mouse cells, mRNA stability assays, quantitative RT-PCR, immunoblot\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined cellular phenotype with mRNA stability measurement, single lab\",\n      \"pmids\": [\"22252322\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Crystal structures of the Dcp2 catalytic Nudix domain reveal binding of a catalytically essential metal ion; active site residues involved in acid/base chemistry of decapping are identified by kinetic analysis; a conserved metal-binding loop undergoes conformational changes during the catalytic cycle as shown by NMR and molecular dynamics.\",\n      \"method\": \"X-ray crystallography, enzyme kinetics (mutagenesis), NMR, molecular dynamics simulations\",\n      \"journal\": \"Structure (London, England : 1993)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus NMR plus kinetics and mutagenesis, multiple orthogonal methods\",\n      \"pmids\": [\"23911090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Dcp2, the catalytic decapping component, and decapping activators DDX6 and LSM7 are antiviral against bunyaviruses in Drosophila; RVFV cap-snatches from Dcp2-targeted mRNAs; loss of Dcp2 increases viral transcription without affecting viral mRNA stability, while Dcp2 overexpression impedes viral transcription.\",\n      \"method\": \"Genome-wide RNAi screen, gain/loss-of-function in cells and flies, RNA-seq, cap-snatching analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined functional role in viral restriction with mechanistic underpinning, multiple readouts, single lab\",\n      \"pmids\": [\"23824541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Maternally recruited DCP1A and DCP2 are translated during mouse oocyte maturation via cytoplasmic polyadenylation; both proteins are phosphorylated during maturation with CDC2A as the likely kinase; inhibition of DCP1A and DCP2 decreases maternal mRNA degradation during meiotic maturation and impairs zygotic genome activation.\",\n      \"method\": \"Immunofluorescence, morpholino/RNAi knockdown, kinase inhibitor experiments, mRNA stability assays in mouse oocytes\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined loss-of-function phenotype with mechanistic phosphorylation analysis, single lab\",\n      \"pmids\": [\"23136299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In human/metazoan cells, EDC4 acts as a scaffold that provides separate binding sites for DCP1, DCP2, and XRN1; DCP2 and XRN1 bind simultaneously to the EDC4 C-terminal domain via short linear motifs; DCP1 and DCP2 form direct but weak interactions that are facilitated by EDC4; the NR-loop in DCP1's EVH1 domain is critical for DCP2 activation; EDC4 couples DCP2 activation with XRN1-mediated 5'-to-3' degradation.\",\n      \"method\": \"Co-immunoprecipitation, pull-down assays, mutagenesis, reporter mRNA decay assays in human cells\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, mutagenesis, and functional reporter assays, multiple orthogonal methods\",\n      \"pmids\": [\"24510189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The Dcp2 C-terminal domain contains distinct conserved negative and positive regulatory elements; a single negative element inhibits enzymatic activity and controls downstream functions; positive elements recruit decapping activators Edc3, Pat1, and Upf1 to form distinct decapping complexes controlling substrate specificity.\",\n      \"method\": \"Genetic analysis of Dcp2 C-terminal deletion/mutation series in S. cerevisiae, mRNA decay assays\",\n      \"journal\": \"RNA (New York, N.Y.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic genetic approach with defined functional readouts, single lab\",\n      \"pmids\": [\"26184073\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Human Dcp2 levels and activity are controlled by competition between decapping complex assembly and ubiquitin-mediated proteasomal degradation; the Dcp2 C-terminal regulatory domain promotes activation via Hedls (EDC4) binding on one hand, and targets uncomplexed Dcp2 for proteasomal degradation on the other.\",\n      \"method\": \"Ubiquitin pathway inhibitors, co-immunoprecipitation, protein stability assays, mutagenesis in human cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined PTM pathway (ubiquitination) with functional consequence, multiple readouts, single lab\",\n      \"pmids\": [\"25870104\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Crystal structure (1.6 Å) of S. pombe Dcp2-Dcp1 in activated conformation stabilized by an intrinsically disordered Edc1 peptide; an unforeseen rotation of the Dcp2 catalytic domain allows residues from both Dcp2 and Dcp1 to cooperate in RNA binding; this explains decapping activation by increased substrate affinity.\",\n      \"method\": \"X-ray crystallography (1.6 Å), mutagenesis, enzyme activity assays\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structure with functional mutagenesis validation\",\n      \"pmids\": [\"27183195\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Crystal structure (2.6 Å) of fission yeast Dcp2-Dcp1-PNRC2 heterotrimer with cap analog reveals a composite nucleotide-binding site formed by conserved residues from both Dcp2 catalytic and regulatory domains; cap binding is accompanied by a conformational change in Dcp2; PNRC2 (a short linear motif coactivator) enhances both substrate affinity and the catalytic step.\",\n      \"method\": \"X-ray crystallography (2.6 Å), enzyme kinetics, mutagenesis\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure combined with kinetic analysis and mutagenesis\",\n      \"pmids\": [\"27694842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Crystal structure of the active form of yeast Dcp1-Dcp2 bound to the reaction product m7GDP and activator Edc3 (K. lactis); provides structural explanation for substrate binding and Edc3-mediated Dcp2 activation.\",\n      \"method\": \"X-ray crystallography, enzyme activity assays\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure of active enzyme-product complex with activator\",\n      \"pmids\": [\"27694841\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Methyl TROSY NMR demonstrates that Dcp2 in solution adopts three domain orientations (open, closed, catalytically active); mRNA substrate, Dcp1, and Edc1 shift dynamic equilibria toward the active state; the active state is only stably formed in the presence of both activators and mRNA substrate or m7GDP product; crystal structure of Dcp1:Dcp2:Edc1:m7GDP complex confirmed active state.\",\n      \"method\": \"Methyl TROSY NMR spectroscopy, X-ray crystallography, enzyme kinetics\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — NMR dynamics with crystal structure and kinetics, multiple orthogonal methods\",\n      \"pmids\": [\"28533364\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Yeast Pat1 C-terminal domain interacts with multiple short HLMs (helical leucine-rich motifs) in the Dcp2 C-terminal region; crystal structures reveal the basis for HLM recognition; Pat1 also interacts with an HLM in Xrn1; Pat1 ability to bind HLMs is required for efficient growth and normal mRNA decay.\",\n      \"method\": \"X-ray crystallography of Pat1-HLM complexes, pull-down assays, mRNA decay assays, yeast genetics\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with mutagenesis and functional validation\",\n      \"pmids\": [\"29078363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Crystal structure (2.84 Å) of K. lactis Dcp1-Dcp2 with coactivators Edc1 and Edc3 and substrate analog in active site; Edc1 forms a three-way interface bridging Dcp2 domains to consolidate the active conformation; Dcp2 has selectivity for the first transcribed nucleotide during catalysis; Edc1 and Edc3 can simultaneously activate decapping.\",\n      \"method\": \"X-ray crystallography (2.84 Å), enzyme kinetics, mutagenesis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure of heterotetrameric complex with substrate analog plus kinetic validation\",\n      \"pmids\": [\"29559651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Yeast Scd6 activates Dcp2-mediated mRNA decapping and mRNA turnover through its LSm domain in vivo; in a dcp2Δ mutant, tethered Scd6 represses translation without reducing mRNA abundance; in a dcp2Δ dhh1Δ double mutant, Scd6 has no impact on mRNA or protein levels; Scd6 and Dhh1 cooperate in translational repression and mRNA turnover of specific native mRNAs.\",\n      \"method\": \"Tethering assay, genetic epistasis (dcp2Δ, dhh1Δ), ribosome profiling, RNA-Seq\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis with multiple deletion combinations, ribosome profiling, RNA-seq, multiple orthogonal methods\",\n      \"pmids\": [\"30532217\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Yeast Pby1 directly binds the Dcp1-Dcp2 decapping complex through its C-terminal domain; crystal structure of Pby1-C-terminal domain bound to Dcp1-Dcp2-Edc3 complex is solved; Pby1 binding requires direct interaction with the decapping enzyme for P-body recruitment; Pby1 binding stimulates growth under conditions of compromised decapping activation.\",\n      \"method\": \"X-ray crystallography, pull-down assays, P-body fluorescence microscopy, yeast growth assays, mutagenesis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with functional mutagenesis and cell biology validation\",\n      \"pmids\": [\"32396195\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"P-body enrichment is the strongest correlate of Dcp2-dependent decay in human cells; m6A modification has an additive effect with P-body enrichment for Dcp2 targeting; global profiling in Dcp2 knockout cells via TimeLapse-seq identified the human Dcp2 regulome.\",\n      \"method\": \"TimeLapse-seq in Dcp2 knockout human cells, bioinformatic correlation analysis\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — clean KO with transcriptome-wide readout but correlative mechanistic inference, single lab\",\n      \"pmids\": [\"32365300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"A bicyclic peptide inhibitor (CP21) selectively binds human DCP2 and inhibits its decapping activity toward selected RNA substrates in human cells; DCP2 inhibition increases P-body formation similar to DCP2 deletion; CP21 enabled identification of 76 previously unreported DCP2 substrates.\",\n      \"method\": \"Phage display selection, biochemical binding assays, cell-based RNA stability assays, P-body fluorescence microscopy\",\n      \"journal\": \"Cell chemical biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — selective chemical inhibitor with cellular validation, multiple readouts, single lab\",\n      \"pmids\": [\"33357462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Yeast Dcp2 C-terminal domain cis-regulatory elements control decapping target specificity: two Upf1-binding motifs direct the enzyme to NMD substrates; a single Edc3-binding motif targets Edc3 and Dhh1 substrates; Pat1-binding leucine-rich motifs target Edc3/Dhh1 substrates under selective conditions; Scd6 and Xrn1 also have specific binding sites on Dcp2.\",\n      \"method\": \"Extensive genetic and mutational analysis in S. cerevisiae, mRNA decay assays, epistasis analysis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — extensive genetic epistasis with multiple binding motif mutations and functional mRNA decay readouts\",\n      \"pmids\": [\"35604319\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Human DCP2 and tristetraprolin (TTP) interact directly via their intrinsically disordered regions (IDRs); this interaction impacts ARE-mRNA stability; the DCP2 IDR has a propensity for oligomerization and liquid-liquid phase separation in vitro; TTP partitions into DCP2 phase-separated droplets, suggesting molecular crowding facilitates assembly of a decapping-competent complex.\",\n      \"method\": \"Pull-down assays, in vitro phase separation assays, mass spectrometry (Urlaub), mRNA stability assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding assay plus in vitro phase separation plus cellular mRNA stability, single lab\",\n      \"pmids\": [\"36130271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MOV10 recruits DCP2 to LINE-1 RNA, forming a MOV10-DCP2-LINE-1 RNP complex with liquid-liquid phase separation properties; DCP2 cooperates with MOV10 to decap LINE-1 RNA, causing LINE-1 RNA degradation and reducing retrotransposition.\",\n      \"method\": \"Co-immunoprecipitation, in vitro phase separation assays, LINE-1 retrotransposition reporter assays, DCP2 overexpression/knockdown\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP demonstrating complex formation, functional retrotransposition assay, single lab\",\n      \"pmids\": [\"37437058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"SSA/Ro52 autoantigen binds human DCP2 at both its N- and C-termini and co-localizes with DCP2 in P-bodies; Ro52 enhances DCP2 decapping activity in a dose-dependent manner.\",\n      \"method\": \"Co-immunoprecipitation, in vitro decapping assay, immunofluorescence co-localization\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP and single in vitro assay, single lab, limited follow-up\",\n      \"pmids\": [\"18361920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Distinct domains of yeast Upf1 make direct contacts with Dcp1/Dcp2, Nmd4, and Ebs1 in the NMD decapping complex; Dcp2 and Upf2 compete for the same binding site on the N-terminal CH domain of Upf1, explaining two mutually exclusive Upf1-containing complexes; Nmd4-assisted recruitment of Upf1 promotes anchoring of the decapping enzyme to NMD target mRNAs.\",\n      \"method\": \"Recombinant protein interaction assays, pull-down with purified components, competition assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — recombinant protein direct binding assays with competition, single lab\",\n      \"pmids\": [\"40071934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In vitro, eIF4E does not interfere with DCP2 decapping function (negative result contradicting prior models); eIF4E binding increases the affinity of Dcp2 for RNA; DCP2 binds RNA with nanomolar affinity as measured by biophysical assays.\",\n      \"method\": \"Purified recombinant proteins, biophysical binding assays, in vitro decapping assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro reconstitution but limited to in vitro conditions, single lab, no cellular validation\",\n      \"pmids\": [\"40748882\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DCP2 is the catalytic subunit of the mRNA decapping complex whose Nudix/MutT domain hydrolyzes the m7GpppN 5' cap to generate m7GDP and a 5'-monophosphorylated RNA substrate for XRN1; its activity is governed by conformational equilibrium between open, closed, and catalytically active states that is promoted by direct binding of Dcp1 (via an EVH1-mediated interaction), coactivators Edc1/Edc2 (which bind Dcp1's EVH1 proline-recognition surface), and Edc3 or Scd6 (which bind helical leucine-rich motifs in the Dcp2 C-terminal domain); in metazoans, EDC4/Hedls serves as a scaffold that simultaneously recruits DCP1, DCP2, and XRN1 to couple decapping with downstream degradation; the large, intrinsically disordered Dcp2 C-terminal extension contains cis-regulatory elements that recruit distinct activator complexes (Edc3, Pat1, Upf1, Scd6, Xrn1) to confer substrate specificity toward NMD substrates, ARE-mRNAs, and other transcript classes, while phosphorylation of Dcp2 by Ste20 and ubiquitin-mediated proteasomal degradation of uncomplexed Dcp2 provide additional post-translational regulatory control of decapping activity.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DCP2 is the catalytic subunit of the eukaryotic mRNA decapping enzyme, hydrolyzing the m7GpppN 5' cap of target mRNAs through its MutT/Nudix domain to produce m7GDP and a 5'-monophosphorylated RNA, thereby committing transcripts to 5'-to-3' degradation and serving as a central node in cytoplasmic mRNA turnover [#0, #1]. Catalysis requires a metal ion coordinated by active-site residues that perform acid/base chemistry, with a metal-binding loop that rearranges during the catalytic cycle [#15]. Decapping is governed by a conformational equilibrium in which DCP2 samples open, closed, and catalytically active states; a conserved gatekeeper tryptophan controls the open-to-closed transition, and mRNA substrate together with the obligate partner DCP1 shifts the equilibrium toward the active conformation, in which residues from both DCP2 and DCP1 cooperate to bind RNA and raise substrate affinity [#7, #13, #21, #24]. The intrinsically disordered DCP2 C-terminal extension carries both an autoinhibitory negative element and an array of positive cis-regulatory motifs—including helical leucine-rich motifs and dedicated binding sites—that recruit coactivators Edc1/Edc2, Edc3, Scd6, Pat1, and Upf1 to assemble distinct decapping complexes conferring substrate specificity toward NMD substrates and other transcript classes [#11, #12, #19, #25, #31]. In metazoans EDC4 (Hedls) acts as a scaffold that simultaneously binds DCP1, DCP2, and XRN1 to couple decapping with downstream exonucleolytic degradation, while uncomplexed DCP2 is targeted for ubiquitin-mediated proteasomal degradation [#18, #20]. DCP2 localizes to and is required for P-bodies, and P-body enrichment is the strongest correlate of DCP2-dependent decay in human cells [#2, #12, #29]. Beyond bulk turnover, DCP2 substrate selection is shaped by 5'-proximal stem-loop structure and the identity of the first transcribed nucleotide, and DCP2 executes regulated decay in miRNA-mediated silencing, innate antiviral responses, oocyte maternal mRNA clearance, and restriction of LINE-1 retrotransposition [#8, #4, #14, #16, #17, #33]. Phosphorylation of DCP2 by Ste20 during stress modulates its interactions and P-body accumulation, adding post-translational control [#9].\"\n,\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing that DCP2 is genetically required for decapping and that its Nudix motif is essential answered whether a dedicated enzyme drives cap removal in vivo.\",\n      \"evidence\": \"Genetic suppressor screen, Co-IP with Dcp1, and in vivo decay assays in yeast\",\n      \"pmids\": [\"10508173\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish whether Dcp2 is itself the catalytic hydrolase or an essential cofactor\", \"Nature of the Dcp1-Dcp2 interaction (direct vs indirect) left open\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Reconstitution of human DCP2 as the catalytically active enzyme producing m7GDP defined DCP2 as the decapping catalyst and showed conservation and P-body localization.\",\n      \"evidence\": \"Recombinant protein, in vitro decapping assay, mutagenesis, immunofluorescence co-localization with hDcp1\",\n      \"pmids\": [\"12486012\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of cap recognition and the structural basis of catalysis unresolved\", \"How DCP1 contributes to activity not yet defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Loss-of-function in Drosophila placed the DCP1:DCP2 complex downstream of miRNA-directed and CCR4:NOT-coupled mRNA decay, connecting decapping to regulated silencing pathways.\",\n      \"evidence\": \"RNAi depletion, reporter mRNA stability and polysome analyses in S2 cells\",\n      \"pmids\": [\"16177138\", \"16815998\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not establish whether DCP2 acts directly on silenced transcripts or downstream of deadenylation\", \"Distinction between decay and translational repression only partially separated\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"In vitro substrate studies showed DCP2 acts on diverse caps (including trimethylguanosine) and is sensitive to 5'-end sequence/structure, beginning to define substrate determinants.\",\n      \"evidence\": \"In vitro decapping with cap analogs and competing RNA across three species\",\n      \"pmids\": [\"16199859\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of TMG decapping in cells not established\", \"Structural basis for 5'-context sensitivity unknown at this stage\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Structural and NMR analyses revealed the bipartite RNA-binding channel and open/closed conformations, establishing that DCP1 stimulates catalysis by stabilizing the closed conformation rather than directly contacting the cap.\",\n      \"evidence\": \"X-ray crystallography of S. pombe Dcp1-Dcp2, SAXS, NMR, kinetics, mutagenesis\",\n      \"pmids\": [\"18280238\", \"18280239\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic geometry of the fully active catalytic state not yet captured\", \"How coactivators beyond Dcp1 reshape the equilibrium unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstration of transcript-specific decapping (Rrp41 5' element) showed DCP2 selectivity confers regulation of individual mRNAs, not just bulk turnover.\",\n      \"evidence\": \"RNA immunoprecipitation, in vitro decapping, RNAi with mRNA stability measurement\",\n      \"pmids\": [\"18039849\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generality of intrinsic sequence-directed selectivity across the transcriptome not tested\", \"Single lab\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identification of 5'-proximal stem-loops as enhancers of DCP2 decapping clarified that secondary structure, not primary sequence, is a key intrinsic substrate determinant.\",\n      \"evidence\": \"In vitro decapping and transfection assays with RNA secondary-structure mutants\",\n      \"pmids\": [\"19233875\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural mechanism by which DCP2 recognizes stem-loops not resolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defining Edc1/Edc2, Edc3, and Ste20-phosphorylation inputs established that coactivators and PTMs tune DCP2 activity, P-body recruitment, and substrate-specific decay.\",\n      \"evidence\": \"Kinetics and mutagenesis (Edc1/Edc2 via Dcp1 EVH1; 1000-fold stimulation), Edc3 peptide-binding mapping, Ste20 kinase assays and P-body microscopy in yeast\",\n      \"pmids\": [\"21148770\", \"20086104\", \"20513766\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How distinct coactivators are selected for particular substrates not yet defined\", \"In vivo writer/eraser dynamics of S137 phosphorylation incomplete\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"The Edc3 LSm–HLM crystal structure showed that multiple helical leucine-rich motifs in the DCP2 C-terminal extension recruit Edc3/Scd6 and are required for P-body localization, defining the C-terminal IDR as a modular activator-docking platform.\",\n      \"evidence\": \"X-ray crystallography, in vitro decapping, P-body microscopy, mutagenesis in yeast\",\n      \"pmids\": [\"22085934\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional division of labor among the multiple HLMs not yet mapped\", \"Competition between Edc3 and Scd6 in vivo consequences unclear at this stage\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"A conserved gatekeeper tryptophan was shown to govern conformational dynamics, mechanistically linking domain motion to coactivation by Edc1.\",\n      \"evidence\": \"NMR dynamics, kinetics, mutagenesis in S. pombe Dcp2\",\n      \"pmids\": [\"22323607\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative populations of conformational states in the catalytic cycle not fully defined here\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Cellular studies extended DCP2 function to regulated programs—innate immunity (IRF-7 mRNA stability) and viral restriction (oocyte/embryo context follows)—showing decapping shapes biological responses.\",\n      \"evidence\": \"Dcp2 hypomorphic mouse cells, mRNA stability assays, RT-PCR, immunoblot\",\n      \"pmids\": [\"22252322\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether IRF-7 is a direct DCP2 substrate not definitively shown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Catalytic-domain structures and kinetics defined the essential metal ion, active-site acid/base residues, and a mobile metal-binding loop, providing the chemical mechanism of cap hydrolysis.\",\n      \"evidence\": \"X-ray crystallography, kinetics/mutagenesis, NMR, molecular dynamics\",\n      \"pmids\": [\"23911090\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Coupling between catalytic-domain chemistry and global conformational activation not fully integrated here\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Genetic/functional studies placed DCP2 in antiviral defense against bunyaviruses and in maternal mRNA clearance during oocyte maturation, broadening its physiological repertoire.\",\n      \"evidence\": \"Genome-wide RNAi screen, RNA-seq and cap-snatching analysis in Drosophila; knockdown and kinase-inhibitor experiments in mouse oocytes\",\n      \"pmids\": [\"23824541\", \"23136299\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking decapping to suppression of viral transcription incompletely defined\", \"Direct DCP2 substrates during oocyte maturation not enumerated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"High-resolution structures of activated Dcp1-Dcp2 with Edc1, PNRC2, Edc3, and cap analog/product captured the catalytically active conformation, showing a catalytic-domain rotation that forms a composite cap/RNA-binding site and explains activation via increased substrate affinity.\",\n      \"evidence\": \"Multiple X-ray structures (1.6–2.84 Å) with kinetics and mutagenesis across fission/budding yeast\",\n      \"pmids\": [\"27183195\", \"27694842\", \"27694841\", \"29559651\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Solution populations of the active state still required orthogonal validation (addressed 2017)\", \"Generalization of short-linear-motif coactivation to metazoan DCP2 not structurally shown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Methyl-TROSY NMR resolved three solution conformations and showed the active state forms only with both activators and substrate/product, completing the dynamic model of conformational selection.\",\n      \"evidence\": \"Methyl TROSY NMR, crystallography of Dcp1:Dcp2:Edc1:m7GDP, kinetics\",\n      \"pmids\": [\"28533364\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How phosphorylation or scaffolds modulate this equilibrium in cells untested here\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defining Pat1 and Scd6 recognition of DCP2 HLMs, and Scd6/Dhh1 cooperation, clarified how distinct activators dock to the C-terminal IDR and couple translational repression with turnover.\",\n      \"evidence\": \"Crystallography of Pat1-HLM complexes; tethering, epistasis, ribosome profiling and RNA-seq for Scd6\",\n      \"pmids\": [\"29078363\", \"30532217\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Combinatorial logic of simultaneous activator occupancy on a single DCP2 not fully resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identification of negative and positive cis-regulatory elements in the DCP2 C-terminal domain, and competition between EDC4-mediated assembly and ubiquitin-driven degradation, established autoinhibition and protein-level control of decapping.\",\n      \"evidence\": \"Genetic deletion/mutation series in yeast; ubiquitin inhibitors, Co-IP, protein-stability assays in human cells\",\n      \"pmids\": [\"26184073\", \"20104\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase targeting uncomplexed DCP2 not identified\", \"Single lab for each system\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"EDC4/Hedls was defined as a metazoan scaffold providing separate binding sites for DCP1, DCP2, and XRN1, physically coupling decapping to 5'-to-3' degradation.\",\n      \"evidence\": \"Reciprocal Co-IP, pull-downs, mutagenesis, reporter decay assays in human cells\",\n      \"pmids\": [\"24510189\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and structural architecture of the full EDC4-bridged assembly unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Transcriptome-wide profiling and a selective chemical inhibitor defined the human DCP2 regulome, showing P-body enrichment as the strongest correlate of DCP2-dependent decay and identifying new substrates.\",\n      \"evidence\": \"TimeLapse-seq in DCP2-KO human cells; bicyclic peptide inhibitor (CP21) with cellular RNA-stability and P-body assays; Pby1 structure for P-body recruitment\",\n      \"pmids\": [\"32365300\", \"33357462\", \"32396195\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causality between P-body partitioning and decay vs correlation unresolved\", \"Direct vs indirect status of many inhibitor-revealed substrates not validated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Phase-separation and IDR-interaction studies (TTP, and Upf1/NMD-substrate targeting motifs) connected DCP2 condensate behavior and C-terminal cis-elements to substrate-class-specific decay.\",\n      \"evidence\": \"Pull-downs, in vitro phase separation, mRNA stability for TTP; extensive genetic/epistasis mapping of Upf1/Edc3/Pat1/Scd6/Xrn1 motifs in yeast\",\n      \"pmids\": [\"36130271\", \"35604319\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo requirement of phase separation for catalysis not established\", \"Quantitative contribution of each motif to specificity incomplete\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"MOV10-directed recruitment of DCP2 to LINE-1 RNA showed DCP2 can be targeted by RNA-binding adaptors to restrict retrotransposition via decapping within phase-separated RNPs.\",\n      \"evidence\": \"Co-IP, in vitro phase separation, LINE-1 retrotransposition reporter assays with DCP2 perturbation\",\n      \"pmids\": [\"37437058\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct decapping of LINE-1 RNA by DCP2 vs indirect effects not fully separated\", \"Single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Mapping of Upf1 contacts and the Upf1/Upf2 competition at the CH domain refined how the NMD decapping complex is assembled and anchored to target mRNAs.\",\n      \"evidence\": \"Recombinant protein interaction and competition assays with purified components\",\n      \"pmids\": [\"40071934\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural model of the full Upf1-anchored decapping complex not determined\", \"In vivo ordering of assembly events not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How DCP2 condensate/phase-separation behavior, conformational dynamics, PTMs, and combinatorial coactivator occupancy are integrated in living cells to select specific substrates remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in-cell measurement linking conformational state to substrate choice\", \"E3 ligase and full PTM code controlling DCP2 abundance unknown\", \"Causal role of P-body/condensate partitioning in catalysis untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [0, 1, 3, 15]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [1, 15, 22]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [5, 6, 8, 36]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0000932\", \"supporting_discovery_ids\": [1, 9, 12, 29]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 1, 4, 31]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [14, 16]}\n    ],\n    \"complexes\": [\n      \"DCP1-DCP2 decapping complex\",\n      \"P-body\",\n      \"EDC4 (Hedls) decapping/XRN1 scaffold complex\",\n      \"Upf1-containing NMD decapping complex\"\n    ],\n    \"partners\": [\n      \"DCP1\",\n      \"EDC3\",\n      \"EDC4\",\n      \"PAT1\",\n      \"UPF1\",\n      \"SCD6\",\n      \"XRN1\",\n      \"MOV10\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}